Last reviewed · How we verify
seminal plasma
At a glance
| Generic name | seminal plasma |
|---|---|
| Sponsor | Ostergotland County Council, Sweden |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Assessment of TetraSOD® Efficacy to Improve Semen Parameters in Men With Idiopathic Infertility (NA)
- A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease (PHASE1, PHASE2)
- Home Semen Testing in Men Beginning Attempts to Conceive (NA)
- Towards Optimal Fertility, Fathering and Fatherhood studY
- Isotretinoin vs hCG for Male Infertility Due to Low or Absent Sperm (PHASE2)
- Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI)
- Effect of Daily Intake of Gazpacho on Semen Quality and Oxidative Stress (NA)
- A First in Human Study, Evaluating the Safety and Efficacy of ADAM™ 1.0 (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- seminal plasma CI brief — competitive landscape report
- seminal plasma updates RSS · CI watch RSS
- Ostergotland County Council, Sweden portfolio CI